Antisense Therapeutics Ltd
ASX:ANP

Watchlist Manager
Antisense Therapeutics Ltd Logo
Antisense Therapeutics Ltd
ASX:ANP
Watchlist
Price: 0.084 AUD 1.2% Market Closed
Updated: May 23, 2024

Antisense Therapeutics Ltd
EPS (Diluted)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Antisense Therapeutics Ltd
EPS (Diluted) Peer Comparison

Comparables:
MYX
NEU
BOT
PBP
C
CU6

Competitive EPS (Diluted) Analysis
Latest Figures & CAGR of Competitors

Company EPS (Diluted) CAGR 3Y CAGR 5Y CAGR 10Y
Antisense Therapeutics Ltd
ASX:ANP
EPS (Diluted)
AU$0
CAGR 3-Years
-26%
CAGR 5-Years
-15%
CAGR 10-Years
0%
Mayne Pharma Group Ltd
ASX:MYX
EPS (Diluted)
AU$1
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Neuren Pharmaceuticals Ltd
ASX:NEU
EPS (Diluted)
AU$1
CAGR 3-Years
N/A
CAGR 5-Years
111%
CAGR 10-Years
N/A
Botanix Pharmaceuticals Ltd
ASX:BOT
EPS (Diluted)
AU$0
CAGR 3-Years
0%
CAGR 5-Years
20%
CAGR 10-Years
27%
Probiotec Ltd
ASX:PBP
EPS (Diluted)
AU$0
CAGR 3-Years
26%
CAGR 5-Years
-15%
CAGR 10-Years
10%
C
Clarity Pharmaceuticals Ltd
ASX:CU6
EPS (Diluted)
AU$0
CAGR 3-Years
-44%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Antisense Therapeutics Ltd's EPS (Diluted)?
EPS (Diluted)
-0 AUD

Based on the financial report for Jun 30, 2023, Antisense Therapeutics Ltd's EPS (Diluted) amounts to -0 AUD.

What is Antisense Therapeutics Ltd's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 10Y
0%

Over the last year, the EPS (Diluted) growth was -100%. The average annual EPS (Diluted) growth rates for Antisense Therapeutics Ltd have been -26% over the past three years , -15% over the past five years .